Immunosuppressive drugs for kidney transplantation

被引:1117
作者
Halloran, PF [1 ]
机构
[1] Univ Alberta, Div Nephrol & Transplantat Immunol, Edmonton, AB, Canada
关键词
D O I
10.1056/NEJMra033540
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2715 / 2729
页数:15
相关论文
共 126 条
[81]   Clinical trials of transplant tolerance: Slow but steady progress [J].
Matthews, JB ;
Ramos, E ;
Bluestone, JA .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (07) :794-803
[82]   Sirolimus-tacrolimus combination immunosuppression [J].
McAlister, VC ;
Gao, ZH ;
Peltekian, K ;
Domingues, J ;
Mahalati, K ;
MacDonald, AS .
LANCET, 2000, 355 (9201) :376-377
[83]   Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era [J].
Meier-Kriesche, HU ;
Schold, JD ;
Srinivas, TR ;
Kaplan, B .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (03) :378-383
[84]   Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection [J].
Meier-Kriesche, HU ;
Steffan, BJ ;
Hochberg, AM ;
Gordon, RD ;
Liebman, MN ;
Morris, JA ;
Kaplan, B .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (01) :68-73
[85]   Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with Sandimmune [J].
Meier-Kriesche, HU ;
Kaplan, B .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (01) :100-104
[86]   IMMUNOSUPPRESSIVE EFFECT OF MYCOPHENOLIC ACID [J].
MITSUI, A ;
SUZUKI, S .
JOURNAL OF ANTIBIOTICS, 1969, 22 (08) :358-&
[87]   A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. [J].
Morice, M ;
Serruys, PW ;
Sousa, JE ;
Fajadet, J ;
Hayashi, EB ;
Perin, M ;
Colombo, A ;
Schuler, G ;
Barragan, P ;
Guagliumi, G ;
Molnar, F ;
Falotico, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1773-1780
[88]  
Morris R.E., 1992, Transpl. Rev, V6, P39, DOI DOI 10.1016/S0955-470X(10)80014-X
[89]  
Nashan B, 1997, LANCET, V350, P1484
[90]   Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients [J].
Nashan, B ;
Moore, R ;
Amlot, P ;
Schmidt, AG ;
Abeywickrama, K ;
Soulillou, JP .
LANCET, 1997, 350 (9086) :1193-1198